Concomitant use of oxycodone HCl with CYP3A4 inducers or discontinuation of the CYP3A4 inhibitor could lower oxycodone plasma concentrations, decrease opioid efficacy or, quite possibly, cause a withdrawal syndrome within a affected individual who experienced produced physical dependence to oxycodone.Cytochrome P450 3A4 Conversation. The concomitan